Citizens reiterates Kura Oncology stock rating on strong trial data

Markets Investing.com By Investing.com 15 Jun 2026 10:07 1 min read

Citizens reiterates Kura Oncology stock rating on strong trial data

Citizens reiterates Kura Oncology stock rating on strong trial data

Citizens reiterates Kura Oncology stock rating on strong trial data

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.